Literature DB >> 23426860

Oxidative stress after a carbohydrate meal contributes to the deterioration of diastolic cardiac function in nonhypertensive insulin-treated patients with moderately well controlled type 2 diabetes.

H von Bibra1, M St John Sutton, T Schuster, A Ceriello, T Siegmund, P-M Schumm-Draeger.   

Abstract

The prevalence and prognostic importance of diastolic dysfunction in type 2 diabetes has only recently been appreciated. We tested the hypothesis that in insulin treated type 2 diabetes (D), carbohydrate consumption induces oxidative stress resulting in further impairment of diastolic function beyond structural myocardial stiffness. The effects of a pure carbohydrate breakfast (48 g) on oxidative stress and cardiac function were studied in the fasting and postmeal states in subjects without hypertension or overt cardiac disease (moderately well controlled D, n=21 and controls without D, n=20). Studied variables included systolic and early diastolic (E') myocardial velocities, traditional metabolic and hemodynamic parameters, serum nitrotyrosine, and sVCAM-1. In D compared to control subjects, the postmeal increase (∆) in glucose (1.44±2.78 vs. 0.11±0.72 mmol/l, p=0.04) and ∆nitrotyrosine (0.34±0.37 vs. -0.23±0.47 nM/l, p<0.001) were significantly higher. sVCAM-1 was higher in fasting and postmeal (p=0.02). E' was significantly lower in postmeal (7.3±1.3 vs. 9.6±1.3 cm/s, p<0.001) and fasting (p<0.001) whereas the rate pressure product was significantly higher (9 420±1 118 vs. 7 705±1 871 mm Hg/min, p<0.001). Multivariable regression models of the pooled data demonstrated that independent predictors for postmeal E' were ∆nitrotyrosine and septal thickness (R² 0.466) and for fasting E' age, ∆nitrotyrosine, and septal thickness (R² 0.400). In insulin requiring type 2 diabetes, carbohydrate consumption may induce oxidative stress that is associated with worsening diastolic function, indicating that this metabolic factor is an important determinant of diastolic dysfunction in the diabetic heart beyond the increase in structural myocardial stiffness. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426860     DOI: 10.1055/s-0033-1333752

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.

Authors:  Zehra Kucukaydın; Cevdet Duran; Mustafa Basaran; Fatos Camlica; Sami Said Erdem; Ahmet Basaran; Orkide Kutlu; Ferda Sevimli Burnik; Halis Elmas; Mustafa Sait Gonen
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

2.  Fast food increases postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot study.

Authors:  Siri Marte Hollekim-Strand; Vegard Malmo; Turid Follestad; Ulrik Wisløff; Charlotte Björk Ingul
Journal:  Nutr J       Date:  2015-08-14       Impact factor: 3.271

Review 3.  Cardiometabolic Syndrome and Increased Risk of Heart Failure.

Authors:  Helene von Bibra; Walter Paulus; Martin St John Sutton
Journal:  Curr Heart Fail Rep       Date:  2016-10

4.  Comparative effects of carbohydrate versus fat restriction on metabolic profiles, biomarkers of inflammation and oxidative stress in overweight patients with Type 2 diabetic and coronary heart disease: A randomized clinical trial.

Authors:  Fariba Raygan; Fereshteh Bahmani; Ebrahim Kouchaki; Esmat Aghadavod; Sahar Sharifi; Elmira Akbari; Akbar Heidari; Zatollah Asemi
Journal:  ARYA Atheroscler       Date:  2016-11

5.  Efficacy of flaxseed oil compared with fish oil supplementation in the treatment of coronary heart disease: a retrospective study.

Authors:  Wei Jiang; Jiangshui Liang; Meng Xiong; Yongqiang Dong
Journal:  J Thorac Dis       Date:  2022-02       Impact factor: 2.895

6.  Effects of analogue insulin in multiple daily injection therapy of type 2 diabetes on postprandial glucose control and cardiac function compared to human insulin: a randomized controlled long-term study.

Authors:  Helene von Bibra; Thorsten Siegmund; Iris Kingreen; Markus Riemer; Tibor Schuster; Petra-Maria Schumm-Draeger
Journal:  Cardiovasc Diabetol       Date:  2016-01-16       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.